GLTO
Price:
$22.89
Market Cap:
$30.38M
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in ...[Read more]
Industry
Biotechnology
IPO Date
2020-10-29
Stock Exchange
NASDAQ
Ticker
GLTO
According to Galecto, Inc.’s latest financial reports and current stock price. The company's current ROE is -130.67%. This represents a change of 297.28% compared to the average of -32.89% of the last 4 quarters.
The mean historical ROE of Galecto, Inc. over the last ten years is -78.72%. The current -130.67% ROE has changed 65.99% with respect to the historical average. Over the past ten years (40 quarters), GLTO's ROE was at its highest in in the March 2018 quarter at 0%. The ROE was at its lowest in in the March 2020 quarter at -11705.97%.
Average
-78.72%
Median
-79.26%
Minimum
-135.42%
Maximum
-21.78%
Discovering the peaks and valleys of Galecto, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 129.67%
Maximum Annual ROE = -21.78%
Minimum Annual Increase = -72.53%
Minimum Annual ROE = -135.42%
| Year | ROE | Change |
|---|---|---|
| 2024 | -135.42% | 14.17% |
| 2023 | -118.61% | 18.06% |
| 2022 | -100.47% | 129.67% |
| 2021 | -43.74% | 100.88% |
| 2020 | -21.78% | -72.53% |
| 2019 | -79.26% | 53.14% |
The current ROE of Galecto, Inc. (GLTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-118.17%
5-year avg
-84.00%
10-year avg
-78.72%
Galecto, Inc.’s ROE is greater than TransCode Therapeutics, Inc. (-1354.71%), greater than Phio Pharmaceuticals Corp. (-86.38%), greater than Aprea Therapeutics, Inc. (-75.30%), greater than Kiora Pharmaceuticals, Inc. (-47.17%), greater than IN8bio, Inc. (-145.52%), greater than Acurx Pharmaceuticals, Inc. (-219.56%), greater than Aptevo Therapeutics Inc. (-675.52%), greater than Lyra Therapeutics, Inc. (-411.98%), greater than Adial Pharmaceuticals, Inc. (-197.71%), greater than BioCardia, Inc. (-58896.55%),
| Company | ROE | Market cap |
|---|---|---|
| -1354.71% | $7.92M | |
| -86.38% | $14.53M | |
| -75.30% | $6.47M | |
| -47.17% | $7.89M | |
| -145.52% | $8.43M | |
| -219.56% | $5.52M | |
| -675.52% | $41.10M | |
| -411.98% | $7.99M | |
| -197.71% | $7.82M | |
| -58896.55% | $8.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galecto, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galecto, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Galecto, Inc.'s ROE?
How is the ROE calculated for Galecto, Inc. (GLTO)?
What is the highest ROE for Galecto, Inc. (GLTO)?
What is the 3-year average ROE for Galecto, Inc. (GLTO)?
What is the 5-year average ROE for Galecto, Inc. (GLTO)?
How does the current ROE for Galecto, Inc. (GLTO) compare to its historical average?